132 episodes

A urology podcast, focussing on all things prostate, kidney, bladder, testis and penile cancer. Join Professor Declan Murphy and Dr Renu Eapen from Peter MacCallum Cancer Centre in Melbourne for this regular dive into the world of genitourinary (GU) Oncology and Urology. Regular guests from all over the world, from every walk of life. Find out more gucast.org 

GU Cast Professor Declan Murphy & Dr Renu Eapen

    • Health & Fitness
    • 5.0 • 2 Ratings

A urology podcast, focussing on all things prostate, kidney, bladder, testis and penile cancer. Join Professor Declan Murphy and Dr Renu Eapen from Peter MacCallum Cancer Centre in Melbourne for this regular dive into the world of genitourinary (GU) Oncology and Urology. Regular guests from all over the world, from every walk of life. Find out more gucast.org 

    Uro-Podcasters Love-in in Lugano!!

    Uro-Podcasters Love-in in Lugano!!

    Great fun on the shores of Lake Lugano where the hosts of three of the best
    -known podcasts in GU Oncology get together for a chat! Declan and Renu from GU Cast, join with Brian and Tom from Uromigos, and Gill from Oncoalert. How did it all start? Why did it all start?! Best moments, worst moments etc. 
    Tune if for a chat, and do please subscribe/like/follow all of us! Just search GU Cast/Uromigos/Oncoalert wherever you get your podcasts 

    • 16 min
    ProsTIC24 PSMA Theranostics Conference Highlights

    ProsTIC24 PSMA Theranostics Conference Highlights

    The 2nd ProsTIC Preceptorship is one of the most intense fora for the discussion of PSMA theranostics anywhere in the world! A biennial meeting in Melbourne with many of the world's leading experts in the field. Not just superb practical advice about how to get your prostate cancer theranostics program to the next level, but some amazing discussions on where to next for theranostics in prostate cancer. Plus, watch out for the shenanigans at the conference dinner!
    Our Conference Highlights are supported by our friends at Bayer China.
    Even better on our YouTube channel 

    • 47 min
    Proton therapy no better than standard prostate radiotherapy

    Proton therapy no better than standard prostate radiotherapy

    A new paper in the Journal of Clinical Oncology is reporting that the bowel and urinary side-effects of proton therapy (a high tech and very expensive type of radiotherapy), are no better than side-effects after standard high-quality radiotherapy (called IMRT). Quite a fuss on twitter when this paper came on line last week including from a fair few urologists, one of whom described proton therapy for prostate cancer as "a black eye for American healthcare"! (Thanks Scott!).
    We chat with lead author Dr James Yu (Hartford, USA), and favourite GU Cast radiation oncologist Prof Shankar Siva to make sense of it all. And what does this mean for proton therapy in places like Australia who currently have no proton therapy facility.

    Even better on our YouTube channel 

    Links:
    JCO paper 

    • 29 min
    ADT and cardiac risks (and how I sold my company for $1.4bn)

    ADT and cardiac risks (and how I sold my company for $1.4bn)

    Professor Neil Fleshner (University of Toronto) drops into the GU Cast studio in Melbourne for an intriguing discussion! First we cover off the underrated topic of cardiac risks in patients starting androgen deprivation therapy and how we can reduce these for the benefit of our patients. Then we talk to Neil about entrepreneurship and his journey into very successful business ventures in recent years. He has some inspiring stories and some great advice for frustrated clinicians out there!
    This episode is a Themed Podcast supported by our Bronze Partners, Cipla Australia.

    Even better on our YouTube channel

    • 32 min
    Happy days for metastatic bladder cancer | Enrique Grande and Andrew Weickhardt

    Happy days for metastatic bladder cancer | Enrique Grande and Andrew Weickhardt

    A big medical oncology love-in in the GU Cast studio today!! Professor Enrique Grande was visiting from MD Anderson Cancer Centre in Madrid to chat all about some of the sensational advances we have seen in metastatic bladder cancer in recent times. And we were also joined by old friend Professor Andrew Weickhardt from Austin Health in Melbourne to educate ourselves on what is an antibody drug conjugate and how does EV work. Plus lots of laughter!!

    Even better on our YouTube channel. , Please do subscribe, rate and review.

    • 32 min
    High risk prostate cancer and mHSPC | With Axel Merseburger

    High risk prostate cancer and mHSPC | With Axel Merseburger

    Axel Merseburger (Chief and Professor of Urology, Lubeck, Germany) was in Australia recently and popped into the GU Cast studio for a chat. Axel was at the USANZ ASM recently and also on a speaker tour supported by Janssen Pharmaceuticals, so we put together this Themed Podcast to pick his brains on high-risk prostate cancer and mHSPC in 2024.
    This Themed Podcast is supported by Janssen Pharmaceuticals, Gold Partners of GU Cast. 

    Even better on our YouTube channel

    • 26 min

Customer Reviews

5.0 out of 5
2 Ratings

2 Ratings

Fardod ,

This is a MUST for UroOnc enthusiasts!!

Fantastic set-up, and hugely informative podcast series by Ireland’s answer to Anderson Cooper (Professor Declan Murphy). This antipodean enterprise gets down to brass tax with all things GU cancer. The list of guests is impressive, and there’s an appropriate level of humour to aid complex discussions. Love this podcast.

Top Podcasts In Health & Fitness

The Mind Full Podcast
Dermot Whelan
Passion Struck with John R. Miles
John R. Miles
ZOE Science & Nutrition
ZOE
Exhibit A
Marvellous
Ready To Be Real by Síle Seoige
Síle Seoige
Feel Better, Live More with Dr Rangan Chatterjee
Dr Rangan Chatterjee: GP & Author

You Might Also Like

European Urology Podcast
Declan Murphy & Joyce Baard
The Uromigos
The Uromigos
What's That Rash?
ABC listen
EAU Podcasts
European Association of Urology
Health Report - Full program podcast
ABC listen
Hidden Brain
Hidden Brain, Shankar Vedantam